ID
27545
Description
Study part: Medical History Screening Day -14 to 0. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.
Keywords
Versions (1)
- 11/20/17 11/20/17 -
Copyright Holder
Charité – University of medicine Berlin
Uploaded on
November 20, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Medical History Screening Day -14 to 0 SirTac NCT02936388
Medical History Screening Day -14 to 0
- StudyEvent: ODM
Description
Vortherapien:
Alias
- UMLS CUI-1
- C1514463
Description
Primary tumor
Data type
text
Alias
- UMLS CUI [1]
- C0677930
Description
Therapy
Data type
text
Alias
- UMLS CUI [1]
- C0087111
Description
Metastases
Data type
text
Alias
- UMLS CUI [1]
- C0027627
Description
Therapy
Data type
text
Alias
- UMLS CUI [1]
- C0087111
Description
long- term medication
Data type
boolean
Alias
- UMLS CUI [1]
- C0420257
Description
date
Data type
date
Alias
- UMLS CUI [1]
- C0011008
Description
investigator name
Data type
text
Alias
- UMLS CUI [1]
- C2826892
Description
investigator signature
Data type
text
Alias
- UMLS CUI [1]
- C2346576
Similar models
Medical History Screening Day -14 to 0
- StudyEvent: ODM
C0677930 (UMLS CUI [1,2])
C0027627 (UMLS CUI [1,2])